A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization.

Yetgin, S; Gürgey, A; Tuncer, A M; Cetin, M; Ozbek, N; Sayli, T; Güler, E; Kara, A; Olcay, L; Duru, F; Gümrük, F; Atahan, L; Tunçbilek, E

Yetgin, S; Gürgey, A; Tuncer, A M; Cetin, M; Ozbek, N; Sayli, T; Güler, E; Kara, A; Olcay, L; Duru, F; Gümrük, F; Atahan, L; Tunçbilek, E.

Affiliation

Yetgin S; Department of Pediatric Hematology, Hacettepe University, Ihsan Dogramaci Children's Hospital, Ankara, Turkey.

Leuk Res ; 22(6): 485-93, 1998 Jun.

Article in En | MEDLINE | ID: mdl-9678714

Subject(s)

Antineoplastic Agents/administration & dosage; Antineoplastic Agents/therapeutic use; Methylprednisolone/administration & dosage; Methylprednisolone/therapeutic use; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Prednisolone/administration & dosage; Prednisolone/therapeutic use; Adolescent; Age Factors; Antineoplastic Agents/adverse effects; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Infant; Infections/etiology; Leukemia, Myeloid, Acute/etiology; Leukocyte Count; Male; Methylprednisolone/adverse effects; Neutropenia/etiology; Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality; Prednisolone/adverse effects; Recurrence; Remission Induction; Risk Factors; Survival Rate; Time Factors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Methylprednisolone / Prednisolone / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Leuk Res Year: 1998 Type: Article Affiliation country: Turkey

Search on Google

XML

PubMed Links